SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is facing significant volatility after federal prosecutors charged the company's co-founder and two other associates with participating in a scheme to illegally smuggle billions of dollars worth of AI server technology into China. While the company stated it is not a named defendant and is cooperating with authorities, investors are aggressively debating the long-term impact on the firm's leadership stability, potential delisting risks, and the security of its critical partnerships.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

Zebec Network is generating significant community buzz due to its strategic expansion into the Stellar ecosystem and anticipation surrounding upcoming major announcements at industry events. Investors are actively discussing the project's long-term utility, tokenomics, and its potential as a disruptor in global payment infrastructure.

Tower Semiconductor Ltd. engages in providing semiconductor solutions. It also offers technology and manufacturing platforms for integrated circuits (ICs) in growing markets such as consumer, industrial, automotive, mobile, infrastructure, medical, and aerospace and defense. It focuses on creating positive and sustainable impact on the world through long term partnerships and its advanced and innovative analog technology offering, comprised of a broad range of customizable process platforms such as SiGe, BiCMOS, mixed-signal/CMOS, RF CMOS, CMOS image sensor, non-imaging sensors, integrated power management (BCD and 700V), and MEMS. Its designs enable a quick and accurate design cycle as well as process transfer services including development, transfer, and optimization, to IDMs and fabless companies. The company was founded in 1993 and is headquartered in Migdal Haemek, Israel.

Tower Semiconductor Ltd.

Tower Semiconductor is trending as investors track the high-stakes regulatory developments surrounding its pending $5.4 billion acquisition by Intel, with community sentiment split between merger-arbitrage optimism and concerns over potential termination. The conversation is heavily focused on the stock's significant discount to the proposed buyout price and the impact of geopolitical tensions on final regulatory approval.

MP Materials Corp. engages in the production and marketing of rare earth specialty materials. It operates through the Materials and Magnetics segments. The Materials segment focuses on the operation of Mountain Pass, which produces refined rare earth oxides and related products, as well as rare earth concentrate products. The Magnetics segment is involved in the operation of Independence Facility, where the company began production of magnetic precursor products. The company was founded by James Henry Litinsky and Michael Rosenthal in 2017 and is headquartered in Las Vegas, NV.

MP Materials Corporation

MP Materials is currently trending due to a combination of market volatility from insider selling and significant investor interest in the company's long-term role as a key supplier for U.S. rare earth production. The community is actively debating the stock's short-term bearish technical trends against its strategic importance in securing domestic supply chains for high-profile partnerships and defense technology.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is gaining traction as critical DeFi infrastructure, with the community highlighting its institutional backing and partnership with the U.S. Department of Commerce to provide macroeconomic data on-chain. Investors are increasingly focused on the project's revenue-sharing model through token buybacks and its emerging role in the Real World Asset sector.

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Portage, MI.

Stryker Corp.

Stryker Corp is facing intense scrutiny and volatility following an Iran-linked cyberattack that disrupted its global operations, with the community actively debating the potential for long-term supply chain damage and massive HIPAA-related liability. While some investors view the temporary stock dip as a value play, others are cautious due to concerns over operational gaps, system restoration timelines, and the broader cybersecurity risks facing the MedTech sector.

Cardano is a blockchain platform built on academic research that enables smart contracts and decentralized applications while using significantly less energy than traditional cryptocurrencies like Bitcoin.   What sets Cardano apart is its methodical, research-driven approach — every major feature is peer-reviewed by scientists and cryptographers before being added to the network. This careful process aims to create a more secure and stable foundation compared to platforms that prioritize speed over thorough testing. The platform's native cryptocurrency, ADA, is used to send money, pay transaction fees, and participate in network governance.  Cardano uses a proof-of-stake system to process transactions, which works differently from Bitcoin's mining approach. Instead of competing to solve complex puzzles, users can "stake" their ADA — essentially locking it up temporarily — to become validators who verify transactions. The system selects validators based on how much ADA they've staked and for how long, then rewards them with additional ADA for their participation. This approach uses far less energy than traditional mining while keeping the network secure. The platform also features a two-layer design that separates basic payment transactions from smart contract operations, allowing each function to be optimized independently for better performance.   ADA holders can earn staking rewards by locking up their tokens to help secure the network, vote on proposed changes to the platform, and use ADA for international money transfers with lower fees than traditional services.  Cardano was founded in 2017 by Charles Hoskinson, who previously helped create Ethereum. Hoskinson leads Input Output Global (IOG), the technology company that builds and maintains Cardano's core software. The ecosystem operates through three organizations: IOG handles technical development, the Cardano Foundation promotes adoption and standardization, and Emurgo helps businesses integrate blockchain technology into their operations. This structure distributes responsibilities across multiple groups rather than concentrating control in a single entity.   In February 2025, major asset manager Grayscale Investments filed to create an exchange-traded fund (ETF) for Cardano with the U.S. Securities and Exchange Commission, which would allow traditional investors to buy ADA through their regular brokerage accounts without needing to set up cryptocurrency wallets.Retry

Cardano

Cardano is experiencing heightened volatility and community debate as investors react to the joint SEC and CFTC classification of the asset as a digital commodity, alongside speculation regarding future infrastructure integrations and broader crypto market trends. While some community members remain focused on long-term accumulation and the potential for a regulatory-driven rally, others express skepticism, pointing to underperformance relative to Bitcoin and broader market uncertainty.

Cheniere Energy, Inc. engages in liquefied natural gas (LNG) related businesses. It owns and operates LNG terminals, develops, constructs, and operates liquefaction projects near Corpus Christi, Texas, and at the Sabine Pass LNG terminal. The company was founded by Charif Souki in 1996 and is headquartered in Houston, TX.

Cheniere Energy Inc.

Cheniere Energy (LNG) is currently trending as a primary beneficiary of surging global natural gas demand, driven by aggressive EU efforts to decouple from Russian energy and the increasing power requirements of AI data centers. Market participants are closely watching the stock for potential inclusion in the S&P 500 while actively debating its valuation against emerging competitors and monitoring the impact of recent geopolitical supply disruptions on broader energy infrastructure.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is at the center of heated investor debate as the market weighs significant progress in FAA certification milestones and potential defense partnerships against concerns over cash burn and competitive legal tensions. The community is actively tracking the company's involvement in the upcoming White House integration pilot programs and the potential impact of its ongoing legal disputes with rival industry players.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart Holdings is facing intense downward pressure and widespread investor frustration, as the community debates whether the stock is a deep-value turnaround play or a failing asset amid sector-wide fintech volatility. While some investors are betting on a potential short squeeze fueled by significant short interest and recent management-led share buybacks, others remain deeply skeptical and vocal about their losses, pointing to broader macroeconomic concerns and the company's persistent inability to sustain upward momentum.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Should Vanguard Russell 1000 Growth ETF (VONG) Be on Your Investing Radar?

<ul class="summary-bullets"><li>DraftKings in Q4 reported revenue of $1,989 million, an increase of 43%, compared to the same period in 2024.</li><li>The increase in the Q4 2025 revenue was driven primarily by continued healthy customer engagement, efficient acquisition of new customers, and higher Sportsbook net revenue margin.&nbsp;</li></ul>DraftKings shares nosedived in after-market hours on Thursday after its full year 2026 forecast fell short of expectations and disappointed investors.&nbsp;It said it is expecting fiscal year 2026 revenue to be in the range of $6.5 billion to $6.9 billion, compared to analysts’ estimates of $7.3 billion, as per data from fiscal.ai.&nbsp;“Our core business is strong as we enter 2026,” said Jason Robins, DraftKings’ Chief Executive Officer and Co-founder. “We also see a massive, incremental opportunity in DraftKings Predictions. We plan to deploy growth capital to build the best customer experience in Predictions, and acquire millions of customers. We have the playbook to execute and win.”<h2 class="st-heading-2">Q4 Highlights</h2>DraftKings for the three months ended December 31, 2025, reported revenue of $1,989 million, an increase of $596 million, or 43%, compared to $1,393 million during the same period in 2024.The increase in the company’s fourth quarter 2025 revenue was driven primarily by continued healthy customer engagement, efficient acquisition of new customers, and higher Sportsbook net revenue margin, according to the company.&nbsp;“We closed 2025 on a high note. Fourth quarter revenue increased 43% year-over-year and we achieved records for revenue and Adjusted EBITDA,” said Robins.&nbsp;DraftKings’ Average Revenue per MUP (“ARPMUP”) was $139 in the fourth quarter of 2025, representing a 43% increase compared to the same period in 2024. The increase was primarily due to higher net revenue margin across both Sportsbook and iGaming.<h2 class="st-heading-2">How Did Stocktwits Users React?</h2>Retail sentiment around DKNG trended in ‘bullish’ territory amid ‘extremely high’ message volume.&nbsp;One user said that the stock will fall further to $14 on Friday.<stembedurl>https://stocktwits.com/viji998/message/644864290</stembedurl>Another user said that they are buying the stock despite noting that revenue guidance is bad.&nbsp;<stembedurl>https://stocktwits.com/undercat22/message/644863726</stembedurl>Shares in the company have fallen 50% over the past year.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/coinbase-stock-rises-despite-posting-surprise-q4-net-loss/cZRTzudR4r6">Coinbase Stock Rises After-Hours Despite Posting Surprise Net Loss In Q4</a>For updates and corrections, email newsroom[at]stocktwits[dot]com. &nbsp;

In this photo illustration, the logo of DraftKings Inc. is displayed on a smartphone screen. 

DraftKings Stock Plummeted 15% After Hours –What Is Driving Such A Selloff?

DraftKings said it is expecting fiscal year 2026 revenue to be in the range of $6.5 billion to $6.9 billion, compared to analysts’ estimates of $7.3 billion, as per data from fiscal.ai. 

Equity

DraftKings said it is expecting fiscal year 2026 revenue to be in the range of $6.5 billion to $6.9 billion, compared to analysts’ estimates of $7.3 billion, as per data from fiscal.ai. 


Here's How Much You Would Have Made Owning Vanguard Russell 1000 Growth ETF Stock In The Last 15 Years

Shares of VONG Now Oversold

In trading on Tuesday, shares of the Vanguard Russell 1000 Growth ETF (Symbol: VONG) entered into oversold territory, changing hands as low as $117.90 per share. We define oversold territory using...

VONG ETF Factor Report

Below is Validea's ETF fundamental report for Vanguard Russell 1000 Growth ETF (VONG). The report looks at VONG's exposure to the major investing factors including value, quality, momentum and low...

Detailed Fundamental Analysis - VONG

Viking Therapeutics has faced a tough start to 2025, with its shares down more than 22% as of Thursday’s close.On Wednesday, the San Diego-based clinical-stage biopharmaceutical company reported a fourth-quarter loss of $0.32 per share, which was wider than the expected $0.27.&nbsp;Viking is still in the development phase and has yet to generate revenue, a common scenario for small- and mid-cap biotech startups.As of Dec. 31, 2024, Viking had $903 million in cash and investments, which it says will help it achieve critical clinical milestones, including completing Phase 3 trials for its subcutaneous version of VK2735, an obesity therapy.In a recent Stocktwits poll, retail traders were asked for their stock price expectations for Viking by the end of 2025.&nbsp;A significant 35%&nbsp;of the poll respondents believe the stock will close below $30, while 32% expect it to rise above $80, a level last seen in late October.&nbsp;Meanwhile, 18% anticipate the stock will end the year between $50 and $80, and 15% see it landing between $30 and $50.<figure class="image"><img style="aspect-ratio:1306/650;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/VKTX_price_prediction_Stocktwits_poll_on_Feb_7_30c9d66fd7.png" alt="VKTX price prediction Stocktwits poll on Feb 7.png" width="1306" height="650"><figcaption>VKTX price prediction Stocktwits poll on Feb 7</figcaption></figure>In 2024, Viking reported positive results from four different clinical trials, including a Phase 2 study for subcutaneous VK2735, a Phase 1 trial of an oral tablet form of VK2735, a Phase 2b study for VK2809 to treat metabolic steatohepatitis (MASH) and fibrosis, and a Phase 1b study of VK0214 for X-linked adrenoleukodystrophy.&nbsp;However, there is growing concern over increased competition in the weight-loss drug market, with Novo Nordisk and Eli Lilly dominating the sector.William Blair and Oppenheimer analysts have speculated that Viking could be an acquisition target for a larger company.&nbsp;This premise gained momentum earlier this week when Novartis CEO Vas Narasimhan revealed that the company is seeking next-generation obesity drug candidates.&nbsp;Shares of Viking spiked on the news, despite Novartis’s own obesity program being in the early stages of development, with no human clinical trials yet.Retail traders on Stocktwits are also bullish on the possibility of a merger or acquisition, especially as Viking’s shares have fallen by over 50% in the past three months.&nbsp;Notably, short interest on Viking has surged from 11.9% in mid-November to over 18% by the end of January.Wall Street’s average price target for Viking is $105.73, representing an upside of more than 230% from current levels.Morgan Stanley analysts, in a note on Thursday, said that after meeting with Viking's management, the company remains confident in securing a commercial manufacturing contract for subcutaneous VK2735, supporting a multibillion-dollar opportunity.The brokerage reiterated its 'Overweight' for the stock and its price target of $105.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Stockbroker analyzing financial stock market with reflection on eyeglasses. Photo via Westend61 on Getty Images

Viking Therapeutics Stock Down Over 20% In 2025: Retail Traders Predict Where It Could End The Year

In 2024, Viking reported positive results from four different clinical trials, including a Phase 2 study for subcutaneous VK2735 and a Phase 1 trial of an oral tablet form of VK2735 to treat obesity.

VONG
Vanguard Russell 1000 Growth Index ETF

Feed

News

Sentiment

Fundamentals

Info

Latest VONG News

VONGVanguard Russell 1000 Growth Index ETF